Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of dexamethasone nanoparticles eye drops in diabetic macular edema

Trial Profile

Efficacy and safety of dexamethasone nanoparticles eye drops in diabetic macular edema

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 08 Sep 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Diabetic macular oedema
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Oculis Pharma
  • Most Recent Events

    • 06 Sep 2022 According to an Oculis Pharma media release, the trial has been published in the Acta Ophthalmologica journal.
    • 05 Oct 2020 Results presented in an Oculis Pharma media release.
    • 05 Oct 2020 According to an Oculis Pharma media release, results from the study were presented at EURETINA 2020 Virtual during the Late Breaking & Reviews session by renowned retina specialist Prof. Ramin Tadayoni, M.D., Ph.D. who is also a member of Oculis's Scientific Advisory Board.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top